1Crisp A J, Chapman CM, Kirkham SE, et al. Articular mastocytosis in rheumatoid arthrits. Rheum, 1984,27: 845-851.
2Folkman J, Klagsbmn M. Angiogenic factors. Science, 1987,235:442-447.
3刘韵源.状态风险分析及其在生物学中的应用.北京:科学出版社,1990.83-98.
4Jaques LB. The mast cell in the light of new knowledge of heparin and sulfated mucopolysaccharides. Gen Pharma, 1975,6: 235.
5Kessler DA, Langer RS, Pless NS, et al. Mast cell and tumor angiogensis.Int J Cancer, 1976,18:703.
6Milliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children:a classification based on endothelial characteristics.Plast Reconstr Surg, 1982,69: 412.
7Esch F, Baird A, Ling N. Protein primary structure of bovine pituitary basic fibroblast growth factor (bFGF) and comparison with the aminoterminal sequence of bovine brain acidic FGF. 1985,82:6507-6511.
8Fishman SJ, Mullken JB. Hemangiomas and vascular malfomations of infancy and childhood. Pediatr Clin North Am, 1993,40: 1177.
9Zhen Hong Qu. Mast cells are a major source of basic fibroblast gowth factor in chronic inflammation and cutaneous hemangioma. Amer J Pathol, 1995,147:564-573.
3SIEGFRIED E C,KEENAN W J,AL-JUREIDINI S.More on propranolol for hemangiomas of infancy[J].N Engl J Med,2008,359(26):2846-2847.
4FRASER K.67th annual meeting of the american academy of dermatology,san francisco california,USA,6210 March 2009[J].Am J Clin Dermatol,2009,10(3):205-210.
5LAUT-LABRZE C,TAEB A.Efficacy of beta-blockers in infantile capillary haemangiomas:the physiopathological significance and therapeutic consequences[J].Ann Dermatol Venerol,2008,135(12):860-862.
6BIAN X W,DU L L,SHI J Q,et al.Correlation of bFGF,FGFR-1 and VEGF expression with vascularity and malignancy of human astrocytomas[J].Anal Quant Cytol Histol,2000,22(3):267-274.
7MULLIKEN J B,GLOWACKI J.Hemangiomas and vascular malfuntions in infants and children:a classification based on endothelial characteristics[J].Plast Reconstr Surg,1982,69(3):412-420.
8RITTER M R,BUTSCHEK R A,FRIEDLANDER M,et al.Pathogenesis of infantile haemangioma:new molecular and cellular insights[J].Expert Rev Mol Med,2007,9(32):1-19.
9LAUT-LABRZE C,Dumas de la ROQUE E,HUBICHE T,et al.Propranolol for severe hemangiomas of infancy[J].N Engl J Med,2008,358(24):2649-2651.
10DENOYELLE F,LEBOULANGER N,ENJOLRAS O,et al.Role of propranol-ol in the therapeutic strategy of infantile laryngotracheal hemangio-ma[J].Int J Pediatr Otorhinolaryngol,2009,73(8):1168-1172.
